New in #JACC: A cross-trial analysis of 3 cardiac amyloidosis #ATTRCM trials reveals time-dependent effects of modern disease-modifying therapies on mortality.

Get the details: www.jacc.org/doi/10.1016/...

#ATTRMeeting2025 #ATTR2025 #Amyloidosis #CardioSky